T38.7X2D Poisoning by androgens and anabolic congeners, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by androgens and anabolic congeners, intentional self-harm, subsequent encounter

Summary

This condition represents intentional self-harm involving poisoning by androgens or anabolic congeners during a subsequent encounter. Androgens and anabolic agents are used for therapeutic purposes (e.g., hormone replacement, anabolic effects) or misused, and intentional self-harm indicates deliberate exposure. The "subsequent encounter" modifier applies when the patient is receiving active treatment for the poisoning during a later phase of care.

Causes

Intentional self-harm poisoning occurs when an individual deliberately ingests or administers androgens or anabolic congeners with the intent to cause harm. This may involve misuse of prescribed medications, non-prescribed substances, or self-administration of these agents. The subsequent encounter modifier indicates ongoing care after the initial treatment phase.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Misuse or non-prescribed use of androgens/anabolic agents
• Access to these substances (e.g., prescriptions, supplements)
• Underlying mental health conditions (e.g., depression, substance use disorders)
• Prior exposure to androgenic agents

Symptoms

Symptoms depend on the agent, dose, and exposure duration. Common manifestations include virilization (e.g., hirsutism, voice deepening), electrolyte imbalances, hepatotoxicity, cardiovascular effects (e.g., hypertension, arrhythmias), or mood changes. Severe cases may involve organ dysfunction or failure.

Diagnosis

Diagnosis requires clinical evaluation, including history of intentional exposure, physical exam findings (e.g., virilization, organ dysfunction), and laboratory tests (e.g., hormone levels, liver/kidney function, toxicology screens). Documentation of intent (self-harm) and encounter timing (subsequent) is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying intent. Interventions may include decontamination, supportive care (e.g., fluid resuscitation, electrolyte correction), monitoring for organ damage, and mental health evaluation. Long-term care may involve psychiatric support or substance use counseling.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying health. Follow-up care typically includes monitoring for delayed complications (e.g., organ dysfunction) and addressing mental health needs. Subsequent encounters ensure ongoing management of both acute and chronic effects.

Complications

Potential complications include persistent organ damage (e.g., liver, kidney), cardiovascular issues, hormonal imbalances, or recurrent self-harm. Long-term effects may require specialized care or lifestyle adjustments.

Lifestyle & Prevention

Prevention involves secure storage of medications, education on safe use, and addressing mental health concerns. For individuals with a history of self-harm, ongoing support and access to mental health resources are critical.

When to Seek Professional Help

Seek immediate care for suspected poisoning, especially with intentional self-harm. Signs include severe symptoms (e.g., organ failure, altered mental status) or uncertainty about exposure. Mental health evaluation is essential for those with suicidal intent.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure clinical notes specify the phase of care (e.g., ongoing treatment after initial stabilization) to justify the "subsequent encounter" modifier. Verify that the poisoning is attributed to androgens or anabolic congeners, with no conflicting documentation.